CORK, Ireland, September 10 Hovione announced today thatTerry Lambe, Ph.D., has been elected to the Board of Directors of Hovione Ltd.
Hovione acquired earlier this year an important API manufacturing sitelocated in Cork. This is a key element of the Hovione strategy to become aleading manufacturer to the pharmaceutical industry.
"We are delighted to welcome Terry Lambe to Hovione. We want to build ourCork site into the ideal, preferred, launch facility for new productintroductions. In the context of the emerging business model based onoutsourcing, our Cork site provides innovator pharmaceutical companies withall the benefits of a top manufacturing facility without the costs ofownership. Terry has a good understanding of what Large Pharma requires andbrings to Hovione a wealth of international experience in manufacturingactivities. We also feel that to do this right it is important to have on theboard of our subsidiary company in Ireland someone familiar with the localculture and with strong links into the Irish pharmachem industry," said GuyVillax, Hovione's Chief Executive. In addition Terry also becomes a member ofthe Hovione Manufacturing Committee that sets out the longer-term productionstrategy for the group.
"I am enthusiastic about joining a successful and dynamic company likeHovione and I hope to be able to make a significant contribution to itsprofitable growth," said Dr. Lambe.
Dr. Terry Lambe joins Hovione following his retirement from Pfizer Inc.in 2008. Dr. Lambe worked at Pfizer for 30 years, during this time he heldroles of increasing responsibility in manufacturing and was responsible forthe construction of several API facilities in Puerto Rico, in Groton,Connecticut and later in Singapore. In 1999, Dr. Lambe assumed his role asVice President, Global Drug Substance. In 2000, he was appointed Team Leader/ Vice President, Ireland / Singapore Manufacturing Area, a position he helduntil 2008. In 2004, Dr. Lambe was awarded the Bio-Link USA - Ireland LifeScience Award for his contribution to the Pharmaceutical Industry. He holds aB.S. and a Ph.D. in Chemistry from University College Cork and completed apost-doctoral fellowship in Electro-Fluorination Chemistry at the Universityof Manchester.
Hovione is an international company with 50 years' experience in activepharmaceutical ingredient development and compliant manufacture. With fourFDA inspected sites in the US, China, Ireland and Portugal the companyfocuses on the most demanding customers in the most highly regulated markets.The company also offers integrated API, particle design and formulationdevelopment and manufacturing. In the inhalation area Hovione is the onlyindependent company offering such a broad range of services.
For more information about Hovione, please visit the Hovione site athttp://www.hovione.com or contact Corporate Communications, Isabel Pina,+351-21-982-9362, e-mail: [email protected]